Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Related Citations for PubMed (Select 24627591)

1.

Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Bolognesi M, Di Pascoli M, Verardo A, Gatta A.

World J Gastroenterol. 2014 Mar 14;20(10):2555-63. doi: 10.3748/wjg.v20.i10.2555. Review.

2.

Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.

Gatta A, Bolognesi M, Merkel C.

Mol Aspects Med. 2008 Feb-Apr;29(1-2):119-29. Epub 2007 Oct 24. Review.

PMID:
18036654
3.

[Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].

Kim MY, Baik SK.

Korean J Gastroenterol. 2009 Sep;54(3):143-8. Review. Korean.

4.

Pathophysiology of portal hypertension.

Cichoz-Lach H, Celiński K, Słomka M, Kasztelan-Szczerbińska B.

J Physiol Pharmacol. 2008 Aug;59 Suppl 2:231-8. Review.

5.

Pathophysiology of portal hypertension.

Iwakiri Y.

Clin Liver Dis. 2014 May;18(2):281-91. doi: 10.1016/j.cld.2013.12.001. Epub 2014 Feb 25. Review.

PMID:
24679494
6.

Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.

Moleda L, Trebicka J, Dietrich P, Gäbele E, Hellerbrand C, Straub RH, Sauerbruch T, Schoelmerich J, Wiest R.

Gut. 2011 Aug;60(8):1122-32. doi: 10.1136/gut.2010.226407. Epub 2011 Feb 12.

PMID:
21317421
7.

Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.

Grace JA, Klein S, Herath CB, Granzow M, Schierwagen R, Masing N, Walther T, Sauerbruch T, Burrell LM, Angus PW, Trebicka J.

Gastroenterology. 2013 Oct;145(4):874-884.e5. doi: 10.1053/j.gastro.2013.06.036. Epub 2013 Jun 22.

PMID:
23796456
8.

Pathophysiology of portal hypertension.

Gupta TK, Chen L, Groszmann RJ.

Clin Liver Dis. 1997 May;1(1):1-12. Review.

PMID:
15562664
9.

Hemodynamic alterations in liver cirrhosis.

La Villa G, Gentilini P.

Mol Aspects Med. 2008 Feb-Apr;29(1-2):112-8. doi: 10.1016/j.mam.2007.09.010. Epub 2007 Oct 24. Review.

PMID:
18177931
10.

Portal hypertension.

Garcia-Tsao G.

Curr Opin Gastroenterol. 2001 May;17(3):281-90.

PMID:
17031170
11.

Causes and pathomechanisms of oesophageal varices development.

Paquet KJ.

Med Sci Monit. 2000 Sep-Oct;6(5):915-28. Review.

PMID:
11208432
12.

Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.

Bosch J, Pizcueta MP, Fernández M, Feu F, Cirera I, Luca A, García-Pagán JC.

Baillieres Clin Gastroenterol. 1992 Sep;6(3):425-36. Review.

PMID:
1421593
14.

Hemodynamic changes in splanchnic blood vessels in portal hypertension.

Colle I, Geerts AM, Van Steenkiste C, Van Vlierberghe H.

Anat Rec (Hoboken). 2008 Jun;291(6):699-713. doi: 10.1002/ar.20667. Review.

15.

Nitric oxide and portal hypertension.

González-Abraldes J, García-Pagán JC, Bosch J.

Metab Brain Dis. 2002 Dec;17(4):311-24. Review.

PMID:
12602508
16.

Portal hypertension.

Garcia-Tsao G.

Curr Opin Gastroenterol. 2003 May;19(3):250-8.

PMID:
15703565
17.

Current concepts on the role of nitric oxide in portal hypertension.

Hu LS, George J, Wang JH.

World J Gastroenterol. 2013 Mar 21;19(11):1707-17. doi: 10.3748/wjg.v19.i11.1707. Review.

18.

Hyperdynamic state in chronic liver diseases.

Groszmann RJ.

J Hepatol. 1993;17 Suppl 2:S38-40. Review.

PMID:
8491969
19.

Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.

Xu J, Cao H, Liu H, Wu ZY.

Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):503-8.

20.

Physiopathology of splanchnic vasodilation in portal hypertension.

Martell M, Coll M, Ezkurdia N, Raurell I, Genescà J.

World J Hepatol. 2010 Jun 27;2(6):208-20. doi: 10.4254/wjh.v2.i6.208.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk